These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 30688868)
1. A Short Communication: Lamotrigine Levels in Milk, Mothers, and Breastfed Infants During the First Postnatal Month. Kacirova I; Grundmann M; Brozmanova H Ther Drug Monit; 2019 Jun; 41(3):401-404. PubMed ID: 30688868 [TBL] [Abstract][Full Text] [Related]
2. Valproic acid concentrations in nursing mothers, mature milk, and breastfed infants in monotherapy and combination therapy. Kacirova I; Grundmann M; Brozmanova H Epilepsy Behav; 2019 Jun; 95():112-116. PubMed ID: 31035102 [TBL] [Abstract][Full Text] [Related]
3. Monitoring of lamotrigine concentrations in mothers, colostrum, and breastfed newborns during the early postpartum period. Kacirova I; Grundmann M; Brozmanova H Biomed Pharmacother; 2022 Jul; 151():113167. PubMed ID: 35617804 [TBL] [Abstract][Full Text] [Related]
4. Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy. Birnbaum AK; Meador KJ; Karanam A; Brown C; May RC; Gerard EE; Gedzelman ER; Penovich PE; Kalayjian LA; Cavitt J; Pack AM; Miller JW; Stowe ZN; Pennell PB; JAMA Neurol; 2020 Apr; 77(4):441-450. PubMed ID: 31886825 [TBL] [Abstract][Full Text] [Related]
5. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Ohman I; Vitols S; Tomson T Epilepsia; 2000 Jun; 41(6):709-13. PubMed ID: 10840403 [TBL] [Abstract][Full Text] [Related]
6. Lamotrigine effects on breastfed infants. Dalili H; Nayeri F; Shariat M; Asgarzadeh L Acta Med Iran; 2015 Jul; 53(7):393-4. PubMed ID: 26520624 [TBL] [Abstract][Full Text] [Related]
7. Lamotrigine in breast milk and nursing infants: determination of exposure. Newport DJ; Pennell PB; Calamaras MR; Ritchie JC; Newman M; Knight B; Viguera AC; Liporace J; Stowe ZN Pediatrics; 2008 Jul; 122(1):e223-31. PubMed ID: 18591203 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Measurements of Intrauterine and Postnatal Exposure to Lamotrigine. Paulzen M; Stingl JC; Augustin M; Saßmannshausen H; Franz C; Gründer G; Schoretsanitis G Clin Pharmacokinet; 2019 Apr; 58(4):535-543. PubMed ID: 30255309 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic monitoring of carbamazepine and its active metabolite during the 1st postnatal month: Influence of drug interactions. Kacirova I; Grundmann M; Brozmanova H Biomed Pharmacother; 2021 May; 137():111412. PubMed ID: 33761618 [TBL] [Abstract][Full Text] [Related]
10. Monitoring topiramate concentrations at delivery and during lactation. Kacirova I; Grundmann M; Brozmanova H; Koristkova B Biomed Pharmacother; 2021 Jun; 138():111446. PubMed ID: 33676308 [TBL] [Abstract][Full Text] [Related]
11. Severe apnea in an infant exposed to lamotrigine in breast milk. Nordmo E; Aronsen L; Wasland K; Småbrekke L; Vorren S Ann Pharmacother; 2009 Nov; 43(11):1893-7. PubMed ID: 19826099 [TBL] [Abstract][Full Text] [Related]
12. Carbamazepine and carbamazepine-epoxide concentrations in mothers, colostrum, and breastfed newborns: Comparison with concentrations determined during delivery and in the mature milk period. Kacirova I; Grundmann M; Brozmanova H Biomed Pharmacother; 2022 Jul; 151():113176. PubMed ID: 35623166 [TBL] [Abstract][Full Text] [Related]
13. Is breast-feeding of infants advisable for epileptic mothers taking antiepileptic drugs? Chen L; Liu F; Yoshida S; Kaneko S Psychiatry Clin Neurosci; 2010 Oct; 64(5):460-8. PubMed ID: 20923425 [TBL] [Abstract][Full Text] [Related]
14. Magnitude of Lamotrigine Exposure Through Breastfeeding. Kohn E; Dinavitser N; Berlin M; Brandriss N; Bar-Chaim A; Gueta I; Keidar R; Livne A; Stepensky D; Berkovitch M; Masarwi M Breastfeed Med; 2022 Apr; 17(4):341-348. PubMed ID: 35049332 [No Abstract] [Full Text] [Related]
15. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Tomson T; Palm R; Källén K; Ben-Menachem E; Söderfeldt B; Danielsson B; Johansson R; Luef G; Ohman I Epilepsia; 2007 Jun; 48(6):1111-6. PubMed ID: 17381438 [TBL] [Abstract][Full Text] [Related]
16. Concerns regarding lamotrigine and breast-feeding. Liporace J; Kao A; D'Abreu A Epilepsy Behav; 2004 Feb; 5(1):102-5. PubMed ID: 14751214 [TBL] [Abstract][Full Text] [Related]
17. Incorporating Breastfeeding-Related Variability with Physiologically Based Pharmacokinetic Modeling to Predict Infant Exposure to Maternal Medication Through Breast Milk: a Workflow Applied to Lamotrigine. Yeung CHT; Ito S; Autmizguine J; Edginton AN AAPS J; 2021 May; 23(4):70. PubMed ID: 34002327 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of lamotrigine during delivery in mothers and their infants. Kacirova I; Grundmann M; Brozmanova H Epilepsy Res; 2010 Oct; 91(2-3):161-5. PubMed ID: 20692811 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Ohman I; Vitols S; Tomson T Epilepsia; 2005 Oct; 46(10):1621-4. PubMed ID: 16190933 [TBL] [Abstract][Full Text] [Related]
20. Perinatal exposure to maternal lamotrigine: clinical considerations for the mother and child. Madadi P; Ito S Can Fam Physician; 2010 Nov; 56(11):1132-4. PubMed ID: 21075992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]